John Davis is listed as an executive officer and director on 3 SEC Form D filings by 2 issuers between Apr 2018 and Mar 2025: Magenta Therapeutics, Inc. (Cambridge, MA — biotechnology — 2018; $52.3M reported sold to 23 investors) and Shift Group Holdings, Inc. (Boston, MA — industry reported as "Other" — 2023–2025; $50K reported sold to 1 investors).
What this means 2 separate companies raised money with this person listed as executive officer and director, over about 7 years. Across those companies the filings report $52.3M sold in total.
Listed alongside John Russell Butler (2 shared filings), Alexis Borisy (1 shared filing), Amy Ronneberg (1 shared filing), Blake Byers (1 shared filing), Bruce Booth (1 shared filing) and 7 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around John. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 6 bankruptcy cases matching the name listed in Key records below.
What this means 6 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 3 public filings for John Davis and found 8 differences: No amendment in the last 12 months on an offering that may still be open; Same name, different state: "John S. Davis" (TX) is a separate record; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.